Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…rapeutic target and predictive biomarker for functional cure in chronic hepatitis B.Abstract IDDF2026-ABS-0371 Figure 1Abstract IDDF2026-ABS-0371 F…
…kade has emerged as a promising approach for functional cure of chronic hepatitis B (CHB).Objective This study aimed to evaluate the safety profile of an…
…e of Study To determine the incidence of young people (YP) with chronic hepatitis B (CHB) who were successfully linked to adult health services (AH…
…ted with HBsAg seroclearance in a large cohort of patients with chronic hepatitis B (CHB).1 The qHBsAg, as a key marker of chronic HBV infection, i…
…logical model, clinical model and combined model for predicting hepatic inflammation. Results The radiological model was constructed by a combinatio…
…tis B surface antigen were higher in HBeAg(+) CHB. Intrahepatic hepatitis B core antigen staining was present in 87% HBeAg(+) but only 13% …
…illion people chronically infected, and is the leading cause of hepatocellular carcinoma worldwide. 1 Tenofovir (TDF) is an effective treatment for HBV …
…The aim of this study was to determine the incidence of YP with chronic Hepatitis B (CHB) successfully transitioning from a specialist paediatric viral h…
…nctional validation constrained generalisability.Conclusions In CHB, scRNA-seq refines rather than transforms concepts of immune dy…
… in order to reduce the risk of liver-related complications and hepatocellular carcinoma (HCC). The aim of this study is to assess the cost-effectivenes…
…001).Conclusion In an endemic population, >40% of patients with CHB have qHBsAg >1000 IU/mL. These patients are unlikely to achieve…
…Background Chronic hepatitis B (CHB) is a major global cause of liver cancer, and metabolic dysfunction-associated steatotic liver disease (…